Viking Therapeutics to Report Financial Results for Second Quarter 2021 on July 28, 2021
Go back to Viking Therapeutics to Report Financial Results for Second Quarter 2021 on July 28, 2021| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 64.93 +1.08 (1.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.85 | 52 Week High | $5.17 | |||
| Open | $64.45 | 52 Week Low | $0.94 | |||
| Day High | $67.58 | P/E | N/A | |||
| Day Low | $63.51 | EPS | $0.00 | |||
| Volume | 2,029,680 | |||||
